Pub. Date : 2017 Jun
PMID : 27324506
1 Functional Relationships(s)Download |
Sentence | Compound Name | Protein Name | Organism |
1 | BACKGROUND AND OBJECTIVES: LCZ696 (sacubitril/valsartan) is a novel angiotensin receptor neprilysin inhibitor (ARNI) that has been developed for treatment of heart failure patients with reduced ejection fraction and approved in the US, Europe, and many other countries. | Valsartan | membrane metalloendopeptidase | Homo sapiens |